AstraZeneca PLC

AstraZeneca PLCverified

AZN

Price:

$66.3

Market Cap:

$202.74B

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/On...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1993-05-12

Stock Exchange

NASDAQ

Ticker

AZN

The Enterprise Value as of December 2024 (TTM) for AstraZeneca PLC (AZN) is 229.51B

According to AstraZeneca PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 229.51B. This represents a change of -8.28% compared to the average of 250.22B of the last 4 quarters.

AstraZeneca PLC (AZN) Historical Enterprise Value (quarterly & annually)

How has AZN Enterprise Value performed in the past?

The mean historical Enterprise Value of AstraZeneca PLC over the last ten years is 142.63B. The current 229.51B Enterprise Value has changed 15.99% with respect to the historical average. Over the past ten years (40 quarters), AZN's Enterprise Value was at its highest in in the June 2024 quarter at 268.63B. The Enterprise Value was at its lowest in in the December 2016 quarter at 81.00B.

Quarterly (TTM)
Annual

Average

142.63B

Median

126.42B

Minimum

81.00B

Maximum

233.69B

AstraZeneca PLC (AZN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AstraZeneca PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 32.83%

Maximum Annual Enterprise Value = 233.69B

Minimum Annual Increase = -14.54%

Minimum Annual Enterprise Value = 81.00B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023233.69B0.32%
2022232.94B21.98%
2021190.97B32.83%
2020143.77B-0.15%
2019143.99B32.01%
2018109.07B6.88%
2017102.05B25.99%
201681.00B-14.54%
201594.78B0.81%
201494.02B24.83%

AstraZeneca PLC (AZN) Average Enterprise Value

How has AZN Enterprise Value performed in the past?

The current Enterprise Value of AstraZeneca PLC (AZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

219.20B

5-year avg

189.07B

10-year avg

142.63B

AstraZeneca PLC (AZN) Enterprise Value vs. Peers

How is AZN’s Enterprise Value compared to its peers?

AstraZeneca PLC’s Enterprise Value is greater than Novartis AG (209.00B), greater than GSK plc (67.53B), less than Roche Holding AG (230.84B), greater than Bristol-Myers Squibb Company (160.66B), greater than Sanofi (131.44B), less than Merck & Co., Inc. (275.11B), greater than Gilead Sciences, Inc. (135.30B), less than Johnson & Johnson (366.92B), less than AbbVie Inc. (381.55B), less than Eli Lilly and Company (783.09B), greater than Pfizer Inc. (216.86B), greater than Amgen Inc. (193.56B),

CompanyEnterprise ValueMarket cap
209.00B$192.42B
67.53B$69.43B
230.84B$225.56B
160.66B$117.15B
131.44B$120.51B
275.11B$251.57B
135.30B$117.09B
366.92B$351.15B
381.55B$317.73B
783.09B$755.34B
216.86B$151.34B
193.56B$142.17B

Build a custom stock screener for AstraZeneca PLC (AZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca PLC (AZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AstraZeneca PLC's Enterprise Value?

What is the highest Enterprise Value for AstraZeneca PLC (AZN)?

What is the 3-year average Enterprise Value for AstraZeneca PLC (AZN)?

What is the 5-year average Enterprise Value for AstraZeneca PLC (AZN)?

How does the current Enterprise Value for AstraZeneca PLC (AZN) compare to its historical average?